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Objective(s): Malaria is an important parasitic disease with high morbidity and mortality in tropical 
areas. Resistance to most antimalarial drugs has encouraged the development of new drugs including 
natural products. Venom is a complex mixture of active pharmaceutical ingredients. The purpose of 
this study was to investigate the antimalarial activity of purified fractions of Naja naja oxiana. 
Materials and Methods: Lyophilized venom was purified with a Sephacryl S-200 HR column and the 
fractions lyophilized and inhibitory concentration 50% against Plasmodium falciparum 3D7 in vitro 
obtained. The 4th fraction was run on a Mono Q column, and activity against P. falciparum was detected by 
lactate dehydrogenase assay and purity by SDS PAGE. Large scale culture of the parasite was carried out 
with and without the active fraction on the ring stage for 48 hr. The parasites were collected and lyophilized 
and analyzed by 1HNMR. Chemometrics studies were performed using MATLAB, differentiating metabolites 
were identified by Human Metabolic Database, and metabolic pathways by the Metaboanalyst online 
package. 
Results: The active fraction from the ion exchange column had a 50% inhibitory concentration of 
0.026 µg/ml on P. falciparum in vitro (P<0.001) with molecular weight of 63 kDa by SDS-PAGE and no 
hemolytic activity. Metabolomics studies on the two groups with and without the fraction identified 5 
differentiating metabolites and a number of related pathways.
Conclusion: The metabolites were succinic acid, l-glutamic acid, pyruvic acid, cholesterol, and NAD. The 
changes in the Krebs cycle and metabolism pathways of nicotinamide and pyruvate were noticeable.  
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Introduction
Malaria is one of the indigenous diseases worldwide, 
especially in tropical countries that has been prevalent 
since ancient times and has caused substantial damage 
to human, social, and economic life.  WHO reports the 
death of 445000 people and 216 million cases of malaria 
(1). Over the past decades, there have been many 
policies concerning communal health and strategies for 
controlling and eradicating malaria. Since the year 2000, 
after enforcing malaria control policies, the number 
of reported cases has been declining significantly. 
According to WHO reports, the prevalence of malaria 
declined by 41% between 2000 and 2015 and the death 
rate decreased by 62% (2). In a similar manner, from the 
year 2011 to 2014, the number of malaria cases in Iran 
decreased from 3572 to 1243 , though it should be noted 
that 57% of the cases were imported from neighboring 
countries (3). Resistance to standard anti-malarial drugs 
still remains a major problem in eradication of malaria 
(4) and there is a constant search for new natural and 
synthetic drugs. 
In recent years, with the progress of science, many 
investigations have been performed on the chemical 
properties of different types of toxins. Snake venom is a 
mixture of proteins with different enzymatic properties, 
consisting of a set of toxic proteins such as neurotoxin, 
cardio-toxin, cytotoxic, mycotoxin, coagulants, and 
anticoagulants, enzymes such as proteases, oxidases, 
phospholipases, and so on. Snake venom as a useful 
biological source contains several active pharmaceutical 
compounds that can be used as medications (5).
Castillo et al. analyzed the Bothrops asper snake 
venom by ion-exchange chromatography and showed 
that the phospholipase A2 and its homolog had 
an anti-plasmodial effect (6). Researchers showed 
that the crotamine polypeptide of South American 
rattlesnake venom exhibited cellular penetration 
properties and was antifungal and antiparasitic. 
It prevented the development of the Plasmodium 
falciparum parasite in a dose-dependent manner 
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with a 50% inhibitory concentration (IC50) of 1.87 μM. 
Crotamine has the ability for selective infiltration into 
RBCs infected with P. falciparum via disturbances in the 
H+ pool and endangers the metabolism of Plasmodium, 
thus inhibiting parasite growth (7).
Metabolomics simultaneously studies small molecules 
or the metabolome in a cell, tissue, or an organ and 
interferes with the primary or secondary metabolism 
using high throughput technology combined with 
chemometrics.  It also analyses metabolic responses 
of live systems to pathophysiological stimuli using 
statistical analysis of biological and Mass spectrometry 
(MS) and 1HNuclear magnetic resonance (1HNMR) 
spectroscopic data.  The metabolomics method that was 
developed by Jeremy Nicholson is the most important 
direct and simultaneous observation of the physiological 
state of the cell (8).
A study used 1HNMR spectroscopy to ascertain the 
effectiveness of aqueous extract of cinnamon on P. 
falciparum metabolome in vitro. The 50% inhibitory 
concentration was detected and after metabolite 
extraction, 1HNMR spectroscopy was performed using 
the NOESY procedure. The data were analyzed by 
chemometric methods, metabolites were recognized 
using the Human Metabolome Databases, and the 
pathways were detected by the Metaboanalyst website. 
They concluded that the aqueous extract of cinnamon 
had an IC50 value of 1.25 mg/ml on P. falciparum in vitro, 
and the differentiating metabolites were succinate acid, 
glutathione, L-aspartic acid, beta-alanine, glycine, and 
2-methylbutyryl. It also affected the main metabolic 
cycles of alanine, aspartate, glutamate, and pantothenate 
and biosynthesis of coenzyme A, lysine and glutathione 
metabolism (9). The most important advantage of 
metabolomics is the simultaneous analysis of the 
metabolites and the relationship between them (10).
There seems to be a lack of comprehensive research 
on the effects of Iranian Cobra snake venom on the 
pathogenesis of Plasmodium. Identification of an 
active fraction of the venom as a candidate for natural 
antimalarial drugs would help in the prevention of drug 
resistance by reducing the use of classical antimalarial 
drugs. In this report, the effect of the active fraction of 
Iranian Naja naja oxiana snake venom on the metabolite 




The lyophilized Naja naja oxiana toxin was obtained 
from the Venom and Pharmaceutical Products 
Laboratory of the Pasteur Institute of Iran.
Gel chromatography
Gel filtration chromatography (Sephacryl S-200 HR-
HI Prep 16/60, GE America) was used to purify the 
fractions of the venom. Crude Iranian cobra venom 
(30 mg) was dissolved in 1 ml of 26 mM ammonium 
acetate (pH 8.0) (MERCK) and centrifuged for 5 min at 
1200 g to remove mucopolysaccharides and particles. 
After measuring the protein in the supernatant, which 
was 10 mg/ml, it was injected into the FPLC (GE, Model 
AKTA) with the S-200 Sephacryl column at a flow rate 
of 8 ml/min. Fractions were collected manually and 
the absorption was measured at 280 nm/215 nm and 
the peaks determined. The run was repeated 6 times 
and the fractions under each peak from each run 
were pooled together and lyophilized to concentrate 
the fractions (Christ Co., Germany), which were then 
used to determine anti-plasmodial activity in vitro by 
microscope counting. 
Ion exchange chromatography
The fraction that exhibited the highest antiparasitic 
effect was purified by ion-exchange chromatography 
and 36 mg of it was dissolved in 2 ml 20 mM Tris-HCl 
and NaCl pH 7.5 and 1 ml injected into the Mono Q 
column (96 x 9.8 cm) of HPLC with a flow rate of 9 ml/
min and eluted with gradient of 0 to 9 M NaCl for 86 
min and absorption recorded at 280/215 nm. The run 
was repeated once more and the fractions were then 
concentrated to 5 ml by dialysis using Amicon Ultra-30 
Centrifugal Filter Units and used to determine the anti-
plasmodial activity in vitro by microscope counting and 
PfLDH assay. 
Protein determination 
Protein content was measured from fractions 
obtained from FPLC chromatography by dissolving the 
lyophilized proteins in 1 ml DW and HPLC fractions 
after dialysis with Amicon Ultra-30 Centrifugal Filter 
Units by the Bicinchoninic Acid method (BCA) using a 
kit (iNtRON Biotechnology Co. South Korea) according 
to the manufacturer’s instructions.
SDS-polyacrylamide gel electrophoresis SDS-PAGE
Was performed on approximately 15 µl of protein 
fractions according to the Laemmli method (11) under 
reducing conditions with 2ME using 12 % resolving gel 
in Tris-HCl pH 8.8 and 4% stacking gel (pH 6.8) in Tris-
glycine  buffer pH 8.3 at 95 volts for 3 hr. The gel was 
stained with Coomassie Blue.
Hemolytic test
5 ml of human blood was obtained using heparin as 
an anticoagulant. Whole blood was washed three times 
with PBS (pH 7.4) and a suspension of 2% was prepared 
in normal saline. Serial dilutions of all fractions up to 
100 µg/ml from FPLC were prepared in a microplate 
and 2% RBC suspension (100 μl) added to each well 
and incubated for 2 hr at 37 °C. The microplate was 
centrifuged for 10 min at 1200 g (Sigma 3-18k), and 
the absorbance of the supernatant was determined at 
540 nm(12) using normal saline as negative control and 
triton X100 was used as the positive control. The percent 
and hemolysis were calculated using this formula:
Percent hemolysis %:100× (OD test– OD negative control)
/ (OD positive control – OD negative control)
MTT assay
Fibroblast cells HEK293 were first cultured in a 75 
ml flask. The cells were then removed from the flask 
with trypsin, and after counting, 20,000 cells were 
transferred to each microplate well, after ensuring that 
the cells were attached to the microplate floor, different 
concentrations of fractions from 6 μg to 180 ng of each 
fraction was added to them. After 24 hr, the supernatant 
of each well was removed, and 100 μl of RPMI 1640 
(sans phenol red) and 50 μl of MTT solution were  added 
and kept at 37 °C under 5% CO2 for 4 hr. Then, 50 μl of 
isopropanol solution was added and the plate was mixed 
in the dark for 15 min, and the absorbance of the samples 
was recorded at 540 nm (by BioTek Epoch device). 
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Culture of parasites
P. falciparum parasite, 3D7 strain was cultured 
according to the procedure of Trager and Jensen (13) 
in the Biochemistry Department of Pasteur Institute of 
Iran.  Briefly, the parasites were cultured in a medium 
containing RPMI 1640 medium (Atocel) supplemented 
with Hepes 5.958 g/l, NaHCO3 2 g/l, gentamicin 25 
mg/l, hypoxanthine 13.6 mg/l, and D-glucose 4.5 g/l, 
along with 10% human serum and 2% hematocrit. The 
medium was replaced every 48 hr, and the flasks were 
incubated at 35.5 °C with 3% CO2, 5% O2, and 90% N2 
(14). The media were replaced daily and the growth of 
the parasite was examined by Giemsa staining of thin 
smear to verify the stage and percentage of parasitemia 
by microscopy.
Synchronization of parasites
Was carried out at the ring stage after obtaining the 
pellet by centrifuging the culture at 600 g and adding 4 
ml of 5% sorbitol followed by incubation for 10 min at 
RT with periodic shaking. The pellet was washed 3 times 
with culture medium and diluted to 5% hematocrit. This 
procedure was once more carried out after 48 hr.  
IC50 Determination 
When the synchronized parasite number reached 
5% in the ring stage, it was diluted to reduce the 
parasitemia to 0.5% and the hematocrit was adjusted to 
1.5%.  This suspension (100 μl) was added to microtiter 
plate wells in triplicate that contained 90 μl of different 
concentrations of the fractions of Naja naja oxiana 
venom from FPLC and HPLC with chloroquine as positive 
control and complete medium as the negative control. 
The plates were incubated at 37 °C for 48 hr in a CO2 
incubator. After that time, a thin smear was prepared 
from each well, stained with Giemsa to determine the 
percentage of parasitemia and IC50 by a microscope 
using the following formula:
Growth inhibition percentage
(parasitemia in control-parasitemia in test)/
parasitemia in control X 100 (15).
Lactate dehydrogenase (LDH) assay
For estimation of parasitemia, the IC50 value was 
confirmed by detecting the lactate dehydrogenase 
enzyme activity of P. falciparum (16). Briefly according to 
the procedure of D’Alessandro, to each well of a 96-well 
plate, 100 µl of Malstate solution was added in duplicate 
and 20 μl of a suspension of medium containing 0.5% 
parasitemia and 1.5% hematocrit was added together 
with different concentrations of the active fraction of 
Naja naja oxiana snake venom using chloroquine as 
positive control and complete medium as negative 
control. Finally, 25 μl solution of phenazine autosulfate 
and nitroblue tetrazolium chloride was added, and the 
absorbance was then read at 620 nm.
The results were expressed as the percentage of 
the viable parasite in drug and control samples by the 
following formula:
100×(ODtreated sample – ODnegative control)/(ODpositive control - 
ODnegative control)
Statistical calculation
 Was carried out in the above tests using Student’s t-test. 
Preparation of parasites and purification of ring-
stage of parasite from RBC on a large scale   
Parasite cultures were grown on a large scale in 
two groups, with and without active fractions and 
centrifuged at 1500 rpm for 5 min, supernatant was 
removed and 20% Saponin was added (40 times the 
parasite volume) and left for 30 min on ice and then the 
solution was centrifuged at 4000 rpm for 4 min at 4 °C. 
The pellet was washed 3 times with PBS (as mentioned 
above), and the purified parasite pellet was centrifuged 
in an Eppendorf tube at 12,000 rpm for 5 to 6 min at 4 
°C. After removal of the supernatant, the samples were 
kept at -20 °C.
Extraction of P. falciparum metabolites
To the frozen purified parasite, 3 ml saline was 
added, sonicated and centrifuged for 10 min at 10,000 
rpm.  The supernatant was removed and for each of 108 
cells, 200 λ cold 1.8 mM perchloric acid was added and 
kept for 1 hr on ice so as to precipitate the metabolites 
with perchloric acid; the sample was kept on ice for 
1 hr and centrifuged at 10,000 rpm for 10 min and 
the supernatant collected.  The pH of the sample was 
adjusted to 6.8 with KOH(5.4M) and lyophilized. For 
1HNMR, 1 ml of D2O was added to the lyophilized powder 
and spectroscopy was carried out using NOESY protocol 
at Central laboratory of technical Isfahan University in a 
400 MHz Bruker device for 5 hr (17). 
 
Analysis of 1HNMR spectra
First, the raw spectra obtained from the 1HNMR 
Bruker were observed using the Mestrec software 
package and then converted into Excel form for 
multivariate chemometrics analysis using the Prometab 
program (version 3_3) on MATLAB (v.7.8.0.347) 
software. Binning was carried out with 0.004 units on 
chemical shifts of 0 to 10 ppm and normalized using 
row-wise normalization, sample median and Pareto 
Scaling. Principle component analysis was carried out 
and then PLS-DA, to obtain VIP scores, was performed 
using the statistical option of the Metabo-analyst website 
(Metaboanalyst.ca) and chemical shifts of differentiating 
metabolites were detected and metabolites identified 
by the Human Metabolome Database at HMDB.Ca. The 
names of the metabolites were entered into the pathway 
analysis of the pathway analysis option of Metaboanalyst 
so as to identify the differentiating metabolic pathways 
between the two groups.
Results
The crude venom was purified by FPLC, and its graph 
is depicted in (Figure 1).
FPLC results of crude venom of Naja naja oxiana 
snake with Sephacryl S-200 column. Fractions obtained 
from 6 runs were pooled together, and protein estimated 
in Table 1.
Protein concentrations of the fractions are shown in 
Table 1.
 MTT assay showed no toxicity of any fraction at any 
dilution on HEK293 cells (Figure 2). The hemolytic effect 
of the fractions at 100 µg/ml is shown in (Figure 3) and 
the 4th fraction lacked it. The 4th and 5th fractions were 
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tested for anti-plasmodial activity and only fraction 4 
exhibited it and its IC50 was seen to be 0.368 µg/ml after 
48 hr with different dilutions 0.368 µg/ml after 48 hr 
with the significance of P<0.001 (Figure 4).
The 4th venom fraction from Sephacryl S-200 had an 
IC50 value of 0.368 µg/ml after 48 hr with significance of 
P<0.001 on P. falciparum  (ring stage) in vitro.
The 4th fraction was separated with ion-exchange 
chromatography (Figure 5) and its protein assayed 
(Table1) and tested on P. falciparum in vitro. The 4th 
fraction alone had anti-plasmodial activity and its IC50 
was obtained both by microscopy counting and PfLDH 
assay (Figure 6), which was 0.026 µg/ml after 48 hr, with 
the significance of P<0.001. This fraction will henceforth 
be named as “active fraction.”  
SDS PAGE of the active fraction with Coomassie Blue 
depicted a single band at approximately 63 kDa (Figure 7). 
Metabolomics of P. falciparum parasite in the presence 
of an active fraction of Naja naja oxiana snake venom 
in vitro 
1HNMR spectra of the peaks of control and active 
 
  
Figure 1. FPC purification of crude venom
Figure 2. MTT assay of venom fractions from Sephacryl S-200 column 
on fibroblast HEK 293 cell line
 
  
Figure 3. Percent hemolytic activity of venom fractions from 
SephacrylS-200 at 100 μg/ml
 
  
Figure 4. The 4th venom fraction from Sephacryl S-200 had an IC50 
value of 0.368 µg/ml after 48 hr with significance of P<0.001 on P. 
falciparum  (ring stage) in vitro
Fractions from ion-exchange HPLC               Fractions from FPLC 
Protein concentration in mg/ml      Name Protein concentration in mg/ml Name 
0.03 F1 0.69 F1 
0.03 F2 3.4 F2 
0.5 F3 8.3 F3 
2.6 F4 36.86 F4 





Table 1. Protein concentration of fractions from columns by the BCA method
 
  Figure 5. HPLC of F4 fraction of crude Naja naja oxiana venom snake 
with ion-exchange Mono Q column (96 x 9.8 cm). The run was repeated 
twice and the fractions were pooled
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fraction on the ring phase of P. falciparum parasite is 
seen in (Figure 8). 
The scree plot from PCA is shown in (Figure 9) with 
92% separation in the first component (Figure 9). Score 
and loading plot of PCA are shown in (Supplement 1, 2).
The variable numbers on the y axis were identified 
as chemical shifts of metabolites (Figure 10). The first 
component of PLS-DA showed a separation of 92.1% 
with their R2and Q2 values (Table 2).
Metabolites with their chemical shifts were identified 
from HMDB (Table 3). 
The main metabolomic pathways identified by 
Metaboanalyst website are seen in Table 4 with their 
P-values in pathway analysis and depicted in Figure 11.
 
  
Figure 6. IC50 of active fraction from Mono Q column on P. falciparum 
in vitro
 
  Figure 7. Coomassie blue staining of SDS-PAGE of fractions from ion 
exchange HPLC with MW markers shown in right hand lane. Lane 4 
showed a single band at 63 KD
 
  
Figure 8. Metabolic spectra of the ring phase in the two groups of con-
trol and Plasmodium falciparum treated with IC50 dose of the active 




Figure 9. The scree plot shows the variance explained by PCs. The 
green line on top shows the accumulated explained variance; the blue 
line underneath shows the variance explained by individual PC
2Q 2R Accuracy Explained variance  
-1 0.2 0.3 92.1% Component 1 
-2 0.25 0.2 7.2% Component 2 
-2 0.5 0.7 0.6% Component 3 
 
  
Table 2. PLS-DA classification using different numbers of components
 
  
Numbers Variation No. Metabolite Name Chemical shift HMDB No. Flux Score values 



































Table 3. Metabolites identified from their chemical shifts 
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Discussion
Venom is considered a biological source of several 
active pharmaceutical compounds. They include 
enzymes such as phospholipases, proteases, oxidases, 
other proteins like disintegrin, neurotoxins, etc., and 
peptides and it is this complex composition that is 
responsible for its deadly effects on the vital systems of 
the body. The highest content of enzymes is observed in 
the snake venoms of which there is only a single oxidase, 
L-amino acid oxidase, but hydrolases are in abundance 
which includes phospholipases А2, proteinases/
peptidases, acetylcholinesterase, and hyaluronidases. 
Non-enzymatic proteins are more varied and it is 
seen that in snakes, it includes the three-finger toxins, 
proteinase inhibitors, disintegrins, nerve growth factor, 
etc. (18). 
Sherman found that the drug ancrod, derived from the 
Malaysian rattlesnake, has a blood-thinning effect and 
 
Numbers Metabolic pathways Total Expected Hits Raw P 
1 Citrate cycle (TCA cycle) 20 0.22272 2 0.017413 
2 Nitrogen metabolism 3 0.033408 1 0.03311 
3 Nicotinate and nicotinamide 7 0.077951 1 0.075886 
4 Propanoate metabolism 12 0.13363 1 0.12721 
5 
Alanine, aspartate and glutamate 
metabolism 
12 0.13363 1 0.12721 
6 Pyruvate metabolism 20 0.22272 1 0.20457 
7 Glycolysis or gluconeogenesis 23 0.25612 1 0.23213 
8 Thiamine metabolism 11 0.12249 1 0.11714 
9 Terpenoid backbone biosynthesis 15 0.16704 1 0.1569 
10 Porphyrin and chlorophyll metabolism 17 0.18931 1 0.17623 
11 Glutathione metabolism 21 0.23385 1 0.21384 
12 Aminoacyl-tRNA biosynthesis 46 0.51225 1 0.41899 
Table 4. The table depicts the differentiating metabolites and pathways in the control and treated Plasmodium falciparum with IC50 dose of active 




Figure 11. Graph showing the metabolic pathway impact of 
differentiating pathways in control and Plasmodium falciparum 
treated with IC50 dose of active fraction of Naja naja groups. The 
x-axis is the pathway impact and the y-axis –log P.  Pathway impact 
between the two groups measured by node importance according to 
relative betweenness centrality; circles larger, higher, or closer to the 
axis are of higher significance. The impact is the pathway impact value 
calculated from the pathway topology analysis. Calculations were 
carried out using the Metaboanalyst website
The second column shows the 5 metabolites that participate in the differentiating pathways, with their significance as detected by the Metaboanalyst 
website. It can be noted that metabolites can be detected in more than one pathway. Since different pathways were tested at the same time, the 
statistical P-values from enrichment analysis were further adjusted for multiple testing. In particular, the total is the total number of compounds 
participating in the pathway; the hits are the actually matched number from the user uploaded data; the raw P is the original P-value calculated 
from the enrichment analysis
Figure 10. Important features’ VIP scores identified by PLS-DA. 
Showing the relative amount of differentiating variable metabolites in 
the two groups of control and Plasmodium falciparum  treated with IC50 
dose of active fraction of Naja naja oxiana snake venom in vitro. The 
colored boxes on the right indicate the relative concentrations of the 
corresponding metabolite in each group under study
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can be used to treat patients immediately after cerebral 
strokes (19). Snake venom is also reported to have 
antitumor activity (20) and has potential for treatment 
of cancer as tested on stomach, colon, adenocarcinoma, 
and leukemia cell lines among others (21) . The venom 
of the Chinese snake Naja naja atra was found to 
selectively act on sarcoma cells and confirmed to have 
antitumor activity, especially on malignant tumors of 
the gastrointestinal tract and gastric cancer (22).
L-amino oxidase is the only oxidase enzyme present in 
the snake venom with important applications.  L-amino-
oxidase isolated from pit viper venom Bothrops jararaca 
is the precursor for Captopril, which is an angiotensin-
converting enzyme inhibitor approved by the USA Food 
and Drug Administration in 1981 (23).
L-amino-oxidase purified by ion-exchange 
chromatography and hydrophobic chromatography 
from Naja naja oxiana is also shown to have antibacterial 
properties and inhibits the growth of gram-positive 
bacteria Bacillus subtilis and gram-negative bacteria 
Escherichia coli (24).
Researchers discovered that a phospholipase A2 
(PLA2) from the eastern diamondback rattlesnake 
(Crotalus adamanteus) inhibits ookinete adhesion and 
oocyst formation. They have also shown that the Crotalus 
adamanteus PLA2 greatly reduces the efficiency of the 
oocyst formation of malaria parasites (25).
Crotamin is a small peptide isolated from the venom 
of the South American rattlesnake Crotalus durissus 
terrificus and is reported to have anti-plasmodial and 
antileishmanial activity. Its mechanism is suggested 
to be the potential involvement of disruption of H+ 
homeostasis in P. falciparum parasites (6).
There has been no report of the anti-plasmodial 
activity of the Iranian cobra venom as yet. Hence, this 
investigation was carried out by purification of the 
venom of the Iranian Naja naja oxiana and its effect on 
the ring stage of P. falciparum. The venom fraction had 
no toxic effect on live cells in vitro as seen in MTT studies 
on fibroblast cells. Also, the active fraction did not have 
any hemolytic activity. In this study, the metabolic 
profile of the P. falciparum  was also analyzed by 1HNMR 
spectroscopy. The venom of Naja naja oxiana was 
purified by two chromatographies and the active fraction 
did not have any hemolytic effect. It is interesting that 
the two methods, both Giemsa staining and LDH assay, 
showed similar results. The active fraction had an IC50 
value of 0.026 µg/ml much higher than the 0.078 µg/ml 
reported for crotamine from South American rattlesnake 
venom on P. falciparum,  which seemed to make it more 
potent (7). Crotamine is a small peptide of 4.8 kDa and 
the dose for IC50 would be higher as compared to the 
active fraction having 63 kDa molecular weight. PLA2 is 
reported to have strong inhibitory effects on the sexual 
stage of the parasites (25), but its presence is unlikely in 
the active fraction from Iranian cobra as this is the main 
enzyme responsible for hemolysis and has a molecular 
weight of 14 kDa. The active fraction obtained from 
Iranian cobra venom did not have any hemolytic activity 
and demonstrated a single line of high molecular weight 
as shown by Coomassie Blue staining and only 0.9% 
hemolytic activity and so it is improbable to contain the 
phospholipase A2 enzyme (26).
This is the first metabolomics study on the activity 
of snake venom on P. falciparum  parasites to date. 
Metabolomic changes in P. falciparum in the control 
and active fraction treated group were detected by 
1HNMR spectroscopy using chemometric methods. 
The metabolites identified participated in a number of 
pathways (Table 4), the most important of which will be 
discussed.
 The first cycle is the Krebs cycle in which succinic 
and pyruvic acids participate. This pathway is closely 
linked to the pyruvate metabolism in which the same 
metabolites are present. Although, early studies 
have shown that the parasite’s blood stage is almost 
entirely dependent on glucose fermentation for energy 
production and minimal oxygen consumption, and the 
parasite can also convert glucose into lactate by the 
glycolysis process during metabolic phases, the parasite 
genes code all the enzymes needed in the Krebs cycle, 
which means it has all the enzymes needed for the TCA 
cycle (27). A study in 2010 showed that the metabolism 
of the Krebs cycle in P. falciparum  is largely separate 
from glycolysis. The main source of carbon for the Krebs 
cycle is aspartate, asparagine, glutamate, and glutamine 
amino acids that are produced by the breakdown of 
the hemoglobin molecule that can be de-aminated and 
converted to oxaloacetate or alpha-ketoglutarate.  They 
believed that the Krebs cycle in this parasite is not like a 
cycle but has a branched structure, and these branches 
in several reactions act in the opposite direction of the 
standard pathway of the Krebs cycle (28), however 
this theory has been refuted (29). The flow of carbon 
in the mitochondria of the parasite is divided into 
two independent branches. One of the branches that 
run counterclockwise begins with carboxylation and 
reduction of oxoglutarate to isocitrate. Isocitrate then is 
converted to citrate and produces two carbons Acetyl Co 
A and oxalate acetate and finally, oxaloacetate converts 
to malate (28). The second branch in the Krebs cycle 
acts in clockwise direction and, during several reactions, 
can oxidize oxoglutarate to succinyl-CoA, succinyl-CoA 
to succinate (succinic acid), succinic acid to fumarate, 
and ultimately fumarate to malate.  The Acetyl-CoA with 
two carbons is the product of this branch that is used for 
histone acetylation. 
Also, acetyl CoA can be obtained from 
phosphoenolpyruvate, which is a product of glycolysis 
in the apicoplast of the parasite, and is used for 
acetylation of amino sugars (28). Glucose consumption 
in red blood cells infected with P. falciparum  parasites 
is more than in uninfected red blood cells. Non-sexual 
proliferation of parasites is also faster. It should be 
noted that reproductive energy in the non-sexual phase 
is provided by the TCA cycle, and in sexual phase is 
provided through glucose because proliferation of the 
gametocytes, in contrast to non-sexual proliferation, 
is sensitive to aconitase inhibitor.  This could be a 
reason for developing drug resistance. During the 
glycolysis pathway (one of the pathways detected), not 
only energy but also pyruvate is produced.  During the 
TCA pathway, energy is also generated; that is malaria 
parasite obtains energy from these two pathways. This 
cycle is indispensable for intracellular growth of the 
parasite(30). The active fraction from the Iranian cobra 
seems to act on this cycle.  There have also been reports 
of a study of the action of Crotalus durissus terrificus 
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venom on rat macrophage metabolism and function and 
it was seen that it increased activities of key enzymes 
of glycolysis and glutaminolysis besides H2O2 and NO 
production and candidacidal activity (31). 
Nicotine amide metabolism pathway is the next 
important one detected. Nicotinamide dinucleotide 
(NAD+) is a necessary metabolite for the malaria 
parasite, which is used as a reducing cofactor and 
enzyme-substrate in multiple cellular processes. NAD+ 
levels have been observed in the red blood cell infected 
with Plasmodium falciparum, but little is known about 
how the parasite produces NAD. In this study, it was 
found that the active fraction of Naja naja oxiana can 
effect this metabolite, and since the metabolic role of 
NAD+ is very important for the parasite, it can be a good 
drug target for antimalarial compounds (32).
The next significant pathway altered is the 
metabolism of alanine, aspartate, and glutamate in 
the P. falciparum  parasite. Our data indicate that 
significant changes occurred in the metabolic pathways 
of alanine, aspartate, and glutamate specifically in the 
adenyl-succinic acid pathway. Previous studies indicated 
that the level of glutamine that is a by-product of this 
metabolic pathway increased in the brains of mice 
infected with malaria while glutamine level decreased 
in the serum (33). Also, oral administration of venom of 
Naja naja altered the aminoacid enzyme levels, such as 
aspartate aminotransferase, alanine aminotransferase, 
and glutamate dehydrogenase in liver cells of mice (34). 
Pyruvic acid participates in terpenoid backbone 
biosynthesis, the next important pathway. Terpenoids 
are also referred to as isoprenoids, which are 
hydrocarbons that participate in vital cellular processes. 
There are reports of P. falciparum terpenoids being used 
in t-RNA isoprenylation and protein including vitamin E 
synthesis, carotenoids, ubiquinone, and dolichols. It is 
interesting that in the plasmodium isoprenoid synthesis 
via the methylerythritol phosphate (MEP) pathway 
is an appealing target for the development of new 
antimalarials. A new regulator of the MEP pathway in P. 
falciparum is detected as HAD1 (PfHAD1) (PlasmoDB 
ID PF3D7_1033400), a sugar phosphatase member 
of the haloacid dehalogenase-like hydrolase (HAD) 
superfamily, which is  detected as a negative regulator 
that acts upstream from the MEP pathway and could be 
further studied as a likely drug target against malaria 
(35).
Glutathione metabolism is an important one altered 
by Naja naja oxiana venom. P. falciparum, as a trophozoite 
in the human red blood cells, shows a severe glutathione 
metabolism. The amino acid glutamine has been 
shown to participate in a number of cycles, especially 
glutathione, which not only plays an important role 
in the antioxidative defense but helps in keeping the 
cytosolic medium at a low pH. Many known glutathione-
associated processes are based on parasite-specific 
lifestyle. Glutathione reduction enables the speed of cell 
growth by providing electrons for deoxyribonucleotide 
synthesis and in sections of heme detoxification, that is, 
supports the product of hemoglobin digestion. Generally, 
free radicals in the parasite can eliminate the sequential 
reactions involved in GS radicals and GS thiolates (36).
Glutathione is conjugated to the indigestible 
compounds such as antimalarial drugs, as glutathione 
S-transferase substrate, it is a well-known detoxification 
cycle.  It is the coenzyme of the glyoxalase system that 
neutralizes methylglyoxal responsible for increasing the 
glycolysis in the trophozoite. Other proteins involved 
in GSH-dependent processes include glutathione 
reductase, glutaredoxin, glyoxalase 1 and 2, glutathione-
s-transferase, and thioredoxin. These proteins and 
ATP-dependent enzymes of glutathione synthesis were 
studied as factors in the pathophysiology of malaria and 
drug targets. Methylene Blue is a well-known structural 
inhibitor of glutathione reductase of P. falciparum  and 
its combination with chloroquine is expected to be a 
promising drug for malaria (37). It is interesting that 
rat liver cells administered Naja haje venom showed 
reduction of glutathione, catalase, glutathione reductase, 
and glutathione-S-transferase activities (38). 
Biosynthesis of the aminoacyl tRNA synthase in the 
Plasmodium-falciparum parasite is the next pathway 
altered by the venom tested. This enzyme is made in two 
steps by the amino-acyl synthase. There are at least 20 
types of these enzymes in each cell. These enzymes play 
an important role in increasing the accuracy of protein 
synthesis. In eukaryotes and prokaryotes, methionine 
and formyl-methionine are the primary amino acids 
in the protein synthesis, respectively. If the activation 
of amino acids is mistaken or there is a problem in the 
amino acid structure, in the place called editing site, the 
link between t-RNA and amino acid hydrolyzes, thereby 
preventing the amino acid from entering into the protein 
structure.
The nucleus of the P. falciparum  has two codes for 
methionyl t-RNA synthetase that are called pfmrscy and 
pfmrsapi and pfmrsapi in the apicoplast of the malaria 
parasite.  This enzyme has been considered for many 
years a drug target for bacteria and fungi, and in recent 
years, considerable research has been done on the 
objective of this enzyme in eukaryotes as a drug target 
(39). It is hoped that in the coming years, this enzyme 
is available as a drug target in parasites. Pham et al., 
over the past decade, have investigated the amino-acyl 
tRNA synthetase in eukaryotic parasites.  The soluble 
crystalline structure of parasitic t-RNA synthase is a 
good drug target for parasites such as P. falciparum (40).
In this report, we showed that in the P. falciparum 
parasite, the active fraction of snake venom could cause 
changes in this enzyme. Our data showed that changes 
have likely occurred in the metabolites of l-isoleucine, 
l-leucine, l-histidine, and l-cysteine in the metabolism of 
aminoacyl-tRNA biosynthesis. 
Conclusion
It can be concluded that the active fraction of Naja naja 
oxiana venom has an inhibitory effect on P. falciparum 
in vitro with IC50 of 0.026 µg/ml with significance of 
P<0.001. This is the most potent anti-plasmodial snake 
venom fraction reported so far. The altered metabolites 
are succinic acid, l-glutamic acid, pyruvic acid, cholesterol, 
and NAD as per the metabolomics study. The data in this 
report demonstrated that in the ring phase, the active 
venom fraction mostly affects the metabolism of amino 
acids and the pathways related to the biosynthesis of 
proteins and isoprenoids. It is for the above reasons that 
the changes in the Krebs cycle and metabolism pathways 
of nicotinamide and pyruvate are noticeable.  
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